Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02461602 · ClinicalTrials.gov registry record

Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

A clinical trial of Atrial Fibrillation, sponsored by Duke University.

Completed
Registry status
251
Enrollment target
20
Study locations

NCT02461602 is a study of Atrial Fibrillation that has completed, run by Duke University. The registered enrollment target is 251 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02461602, a study of Atrial Fibrillation, has completed, sponsored by Duke University.

COMPLETED
Registry status
251 participants
Enrollment target
20
Study locations

Study Summary

ELITE (Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients) is a two year research project to assess warfarin management issues faced by atrial fibrillation (AF) patients in ambulatory settings.

Conditions Studied

Atrial Fibrillation

Study Locations (20)

Florida

  • Holy Cross Medical Group - Coral Springs
  • Charlotte Heart Group - Port Charlotte

Georgia

  • Atlanta Institute for Medical Research, Inc. - Atlanta
  • Atlanta Heart Specialists - Cumming

Michigan

  • Endeavor Medical Research - Alpena
  • Great Lakes Heart and Vascular Institute - Saint Joseph

New Jersey

  • Cardiovascular Associates of the Delaware Valley - Elmer
  • Lourdes Cardiology Services - Voorhees Township

Texas

  • North Texas Research Associates - Allen
  • Providence Health Center - Waco

California

  • Foothill Cardiology - Pasadena

Indiana

  • Cardiovascular Research of Northwest Indiana, L.L.C. - Munster

Kentucky

  • Research Integrity, LLC. - Owensboro

Trial Details

FieldValue
Enrollment Target 251 participants
Start Date 2016-02
Est. Completion 2018-05-31

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02461602

The ClinicalTrials.gov registry entry for NCT02461602 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.

NCT02461602 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Florida, Georgia, Michigan.

Frequently Asked Questions

What is clinical trial NCT02461602 about?

NCT02461602 is a clinical study titled "Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients". ELITE (Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients) is a two year research project to assess warfarin management issues faced by atrial fibrillation (AF) patients in ambulatory settings.

What is the current status of trial NCT02461602?

This trial is currently completed. The enrollment target is 251 participants. The study started on 2016-02. Estimated completion is 2018-05-31.

What conditions does trial NCT02461602 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

Who is sponsoring clinical trial NCT02461602?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02461602 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.